Handa Oncol Drug Patent Portfolio
Handa Oncol owns 1 orange book drug protected by 6 US patents Given below is the list of Handa Oncol's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12415784 | Cabozantinib Compositions And Methods Of Use | 30 Jan, 2044 | Active |
| US12516025 | Cabozantinib Compositions And Methods Of Use | 30 Jan, 2044 | Active |
| US12552567 | Method For Packaging Articles In Boxes And Packaging Device Operating According To Such A Method | 30 Jan, 2044 | Active |
| US12552749 | Cabozantinib Compositions And Methods Of Use | 30 Jan, 2044 | Active |
| US12741938 | Cabozantinib Compositions And Methods Of Use | 30 Jan, 2044 | Active |
| US12064430 | Kinase Inhibitor Salts And Compositions Thereof | 13 Jun, 2039 | Active |
Handa Oncol's Family Patents
Handa Oncol Drug List
Given below is the complete list of Handa Oncol's drugs and the patents protecting them.
1. Omcazio
Omcazio is protected by 6 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US12415784 | Cabozantinib Compositions And Methods Of Use |
30 Jan, 2044
(17 years from now)
| Active |
| US12516025 | Cabozantinib Compositions And Methods Of Use |
30 Jan, 2044
(17 years from now)
| Active |
| US12552567 | Method For Packaging Articles In Boxes And Packaging Device Operating According To Such A Method |
30 Jan, 2044
(17 years from now)
| Active |
| US12552749 | Cabozantinib Compositions And Methods Of Use |
30 Jan, 2044
(17 years from now)
| Active |
| US12741938 | Cabozantinib Compositions And Methods Of Use |
30 Jan, 2044
(17 years from now)
| Active |
| US12064430 | Kinase Inhibitor Salts And Compositions Thereof |
13 Jun, 2039
(12 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Omcazio's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List